🍽️ lactobacillus delbrueckii bulgaricus,bifidobacterium bifidum,enterococcus faecium,candida pintolopesii,aspergillus oryzae (probiotics)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of lactobacillus delbrueckii bulgaricus,bifidobacterium bifidum,enterococcus faecium,candida pintolopesii,aspergillus oryzae (probiotics) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by lactobacillus delbrueckii bulgaricus,bifidobacterium bifidum,enterococcus faecium,candida pintolopesii,aspergillus oryzae (probiotics)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Lachnospiraceae family Decreases 👪 Source Study
Bacteroidaceae family Increases 👪 Source Study
Eubacteriales Family IV. Incertae Sedis family Increases 📓 Source Study
Blautia genus Decreases 📓 Source Study
Bacteroides genus Increases 📓 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Blautia no rank Decreases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Bacteroides no rank Increases 👶 Source Study
Eubacteriales incertae sedis no rank Increases 👪 Source Study
unclassified Bacteroides no rank Increases 👪 Source Study
Blautia argi species Decreases 👶 Source Study
Blautia caecimuris species Decreases 👶 Source Study
Blautia coccoides species Decreases 👶 Source Study
Blautia difficilis species Decreases 👶 Source Study
Blautia faecicola species Decreases 👶 Source Study
Blautia faecis species Decreases 👶 Source Study
Blautia glucerasea species Decreases 👶 Source Study
Blautia hansenii species Decreases 👶 Source Study
Blautia hominis species Decreases 👶 Source Study
Blautia hydrogenotrophica species Decreases 👶 Source Study
Blautia intestinalis species Decreases 👶 Source Study
Blautia liquoris species Decreases 👶 Source Study
Blautia luti species Decreases 👶 Source Study
Blautia marasmi species Decreases 👶 Source Study
Blautia massiliensis (ex Durand et al. 2017) species Decreases 👶 Source Study
Blautia obeum species Decreases 👶 Source Study
Blautia producta species Decreases 👶 Source Study
Blautia pseudococcoides species Decreases 👶 Source Study
Blautia schinkii species Decreases 👶 Source Study
Blautia stercoris species Decreases 👶 Source Study
Blautia tarda species Decreases 👶 Source Study
Blautia wexlerae species Decreases 👶 Source Study
Bacteroides acidifaciens species Increases 👶 Source Study
Bacteroides caccae species Increases 👶 Source Study
Bacteroides caecigallinarum species Increases 👶 Source Study
Bacteroides caecimuri species Increases 👶 Source Study
Bacteroides caecimuris species Increases 👶 Source Study
Bacteroides cellulosilyticus species Increases 👶 Source Study
Bacteroides chinchillae species Increases 👶 Source Study
Bacteroides clarus species Increases 👶 Source Study
Bacteroides coprosuis species Increases 👶 Source Study
Bacteroides denticanum species Increases 👶 Source Study
Bacteroides eggerthii species Increases 👶 Source Study
Bacteroides faecalis species Increases 👶 Source Study
Bacteroides faecichinchillae species Increases 👶 Source Study
Bacteroides faecis species Increases 👶 Source Study
Bacteroides faecium species Increases 👶 Source Study
Bacteroides finegoldii species Increases 👶 Source Study
Bacteroides fluxus species Increases 👶 Source Study
Bacteroides fragilis species Increases 👶 Source Study H02076 Bacteroides infection
Bacteroides galacturonicus species Increases 👶 Source Study
Bacteroides gallinaceum species Increases 👶 Source Study
Bacteroides gallinarum species Increases 👶 Source Study
Bacteroides graminisolvens species Increases 👶 Source Study
Bacteroides helcogenes species Increases 👶 Source Study
Bacteroides heparinolyticus species Increases 👶 Source Study
Bacteroides humanifaecis species Increases 👶 Source Study
Bacteroides ihuae species Increases 👶 Source Study
Bacteroides intestinalis species Increases 👶 Source Study
Bacteroides koreensis species Increases 👶 Source Study
Bacteroides kribbi species Increases 👶 Source Study
Bacteroides luhongzhouii species Increases 👶 Source Study
Bacteroides luti species Increases 👶 Source Study
Bacteroides mediterraneensis species Increases 👶 Source Study
Bacteroides ndongoniae species Increases 👶 Source Study
Bacteroides nordii species Increases 👶 Source Study
Bacteroides oleiciplenus species Increases 👶 Source Study
Bacteroides ovatus species Increases 👶 Source Study
Bacteroides propionicifaciens species Increases 👶 Source Study
Bacteroides pyogenes species Increases 👶 Source Study
Bacteroides reticulotermitis species Increases 👶 Source Study
Bacteroides rodentium species Increases 👶 Source Study
Bacteroides salyersiae species Increases 👶 Source Study
Bacteroides sp species Increases 👶 Source Study
Bacteroides sp. C13EG172 species Increases 👶 Source Study
Bacteroides stercorirosoris species Increases 👶 Source Study
Bacteroides stercoris species Increases 👶 Source Study
Bacteroides thetaiotaomicron species Increases 👶 Source Study
Bacteroides timonensis species Increases 👶 Source Study
Bacteroides uniformis species Increases 👶 Source Study Infectious bacteria
Bacteroides xylanisolvens species Increases 👶 Source Study
Bacteroides zhangwenhongii species Increases 👶 Source Study
Bacteroides zoogleoformans species Increases 👶 Source Study
Bacteroides sp. species Increases 📓 Source Study

Impact of lactobacillus delbrueckii bulgaricus,bifidobacterium bifidum,enterococcus faecium,candida pintolopesii,aspergillus oryzae (probiotics) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.3 -0.3
ADHD 0.6 -0.6
Age-Related Macular Degeneration and Glaucoma 0.3 -0.3
Allergic Rhinitis (Hay Fever) 0.6 -0.6
Allergies 0.4 0.8 -1
Allergy to milk products 0.4 0.6 -0.5
Alopecia (Hair Loss) 0.8 0.2 3
Alzheimer's disease 1.3 1.5 -0.15
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.3 0.4 -0.33
Ankylosing spondylitis 1.4 0.8 0.75
Anorexia Nervosa 0.6 0.8 -0.33
Antiphospholipid syndrome (APS) 0.2 -0.2
Asthma 1 0.3 2.33
Atrial fibrillation 1.1 0.6 0.83
Autism 1.6 1.4 0.14
Bipolar Disorder 0.6 -0.6
Brain Trauma 0.6 0.6
Carcinoma 1.1 1.1 0
Celiac Disease 0.8 1.1 -0.38
Cerebral Palsy 0.6 0.5 0.2
Chronic Fatigue Syndrome 0.6 1.7 -1.83
Chronic Kidney Disease 0.8 -0.8
Chronic Lyme 0.6 0.6
Chronic Obstructive Pulmonary Disease (COPD) 0.3 0.3
Chronic Urticaria (Hives) 0.2 0.2
Coagulation / Micro clot triggering bacteria 0.5 -0.5
Colorectal Cancer 0.6 1.1 -0.83
Constipation 0.3 1.6 -4.33
Coronary artery disease 0.3 0.8 -1.67
COVID-19 3.4 2.9 0.17
Crohn's Disease 1.5 1.9 -0.27
cystic fibrosis 0.6 0.6
Depression 1.8 3.1 -0.72
Eczema 0.2 0.3 -0.5
Endometriosis 0.5 0.6 -0.2
Epilepsy 1.4 1.5 -0.07
erectile dysfunction 0.3 0.3
Fibromyalgia 1.6 0.4 3
Functional constipation / chronic idiopathic constipation 1.3 1.5 -0.15
gallstone disease (gsd) 0.5 0.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.7 -0.7
Generalized anxiety disorder 1.1 1.1
Glioblastoma 0.3 -0.3
Gout 0.6 -0.6
Graves' disease 1.4 -1.4
Halitosis 0.6 -0.6
Hashimoto's thyroiditis 1.4 0.6 1.33
Histamine Issues,Mast Cell Issue, DAO Insufficiency 1.1 -1.1
hyperglycemia 0.8 0.5 0.6
hypersomnia 0.5 -0.5
hypertension (High Blood Pressure 0.8 1.4 -0.75
Hypothyroidism 0.8 -0.8
Hypoxia 0.6 -0.6
IgA nephropathy (IgAN) 1.1 1.1
Inflammatory Bowel Disease 0.8 1.3 -0.63
Insomnia 1.4 0.6 1.33
Intelligence 0.3 0.2 0.5
Intracranial aneurysms 0.5 0.6 -0.2
Irritable Bowel Syndrome 1.3 1.5 -0.15
Liver Cirrhosis 1.4 0.6 1.33
Long COVID 1.8 2.2 -0.22
Low bone mineral density 0.3 -0.3
Lung Cancer 0.9 -0.9
ME/CFS with IBS 0.6 0.2 2
ME/CFS without IBS 0.6 0.6
Menopause 0.2 -0.2
Metabolic Syndrome 1.5 2.1 -0.4
Mood Disorders 1.8 3.1 -0.72
multiple chemical sensitivity [MCS] 0.5 -0.5
Multiple Sclerosis 1.5 0.3 4
Multiple system atrophy (MSA) 0.5 -0.5
Neuropathy (all types) 0.8 0.8
neuropsychiatric disorders (PANDAS, PANS) 0.6 -0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.1 0.9 0.22
Obesity 1.9 1.5 0.27
obsessive-compulsive disorder 0.8 1.9 -1.37
Osteoarthritis 0.3 0.6 -1
Osteoporosis 0.6 1.1 -0.83
Parkinson's Disease 0.2 1.1 -4.5
Polycystic ovary syndrome 0.8 0.6 0.33
Premenstrual dysphoric disorder 0.5 0.5
primary biliary cholangitis 0.4 0.4
Psoriasis 1.1 0.2 4.5
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.8 1.3 0.38
Schizophrenia 0.3 1.3 -3.33
scoliosis 0.3 0.3
sensorineural hearing loss 0.3 -0.3
Sjögren syndrome 1.3 0.8 0.63
Sleep Apnea 1.1 0.5 1.2
Stress / posttraumatic stress disorder 0.8 0.8 0
Systemic Lupus Erythematosus 0.5 1.8 -2.6
Tourette syndrome 0.6 0.6
Type 1 Diabetes 0.8 1 -0.25
Type 2 Diabetes 1.7 1.9 -0.12
Ulcerative colitis 1.8 1 0.8
Unhealthy Ageing 0.8 -0.8

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)